Chromosomal rearrangements involving the ROS1 receptor tyrosine kinase gene represent a unique subset of molecular drivers seen in ~1–2% of all non-small cell lung cancers (NSCLCs)1. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.